Site Search
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Pediatric Phlebotomy with Pain Management: Creating an Optimal Experience - Insights
This “Phlebotomy” webinar reviews: Having a medical procedure or a lab draw can be fearful for children. Even if it is their first time or they have had a bad past experience, there are ways to make these procedures easier for children.
Toxicology testing for patient care - Insights
In this episode, Paul Jannetto, Ph.D., associate professor of laboratory medicine and pathology and director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab at Mayo Clinic, discusses how his three...
Week in Review: March 3 - Insights
Today's Highlights Include: COVID-19 deaths remain low compared to previous winters, FDA authorizing first at-home combo flu/Covid test, and Rochester public schools evaluating mental health needs and services throughout the district.
Mayo Clinic Minute: What Are the "ABCs" of Avoiding Ticks? - Insights
It's time to start preparing for what could be a bumper crop of ticks across the U.S. As the last of the winter's snow melts, ticks start coming up from under the grass looking for a blood meal. In this Mayo Clinic Minute, Dr. Bobbi Pritt,...
Ticks and the Art of Finding Beauty in Dreadful, Wonderful Parasites - Insights
Bobbi Pritt, M.D., spends her work hours identifying and diagnosing infectious diseases. In her free time, she celebrates their beauty by creating bug-related artwork and blogging about parasites.
Bobbi Pritt, M.D., on the Lone Star Tick: Mayo Clinic Radio "Health Minute" - Insights
In this Mayo Clinic Radio "Health Minute," Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services at Mayo Clinic, explains how the lone star tick's bite can cause an allergic...
Tick Dragging with Bobbi Pritt, M.D. - Insights
On a recent tick drag with Minnesota Department of Health researchers, Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and...
What You Should Know about Rocky Mountain Spotted Fever - Insights
A Wisconsin woman has died of Rocky Mountain spotted fever in what Wisconsin health officials have confirmed is the first documented death from the infection in the state. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory...
Conveying the Value of the Hospital Laboratory - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with Erin Hoffman, division director of hospital sales and services at Mayo Clinic...
Marketing Strategies and Considerations for the Outreach Laboratory - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with Andrew Tofilon, director of marketing at Mayo Clinic Laboratories. They discuss...
Maintaining Quality Within an Outreach Program - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with quality management coordinator Kate Pearce about optimizing preanalytic quality...
Understanding Laboratory Regulations - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with Shannon Bennett, director of regulatory affairs for the Department of Laboratory...
Neuro-oncology informative cases - Insights
Clinical studies at the Mayo Clinic have shown that this broad, but tumor-specific, genetic analysis has significant, and sometimes unexpected, clinical impact. The following case studies highlight the importance and clinical utility of...
Pediatric neuro-oncology informative cases - Insights
Neuro-oncology is a complex field undergoing rapid changes with the advancement and evolution of sophisticated genetic testing. Evidence continues to grow in support of broad molecular and cytogenetic analysis for patients with brain...
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
At Mayo Clinic, we offer a comprehensive approach to testing that focuses on the best outcomes for the patient. Our testing method combines molecular and cytogenetic analysis (in addition to a standard morphological and histological...
Practical aspects & pitfalls in molecular diagnosis of brain tumors - Insights
Practical aspects and pitfalls in the molecular diagnosis of brain tumors.
Neuropathology Consultations - Mayo Clinic Laboratories
Our second-opinion consultations give neuropathologists access to Mayo Clinic neuropatholgists who can help choose the most appropriate molecular and cytogenetic testing.
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 18 - Insights
This week’s Research Roundup highlights Mayo Clinic researchers who conducted a study to characterize the clinical, pathologic, and survival implications of non-V600 BRAF mutations in metastatic colorectal cancer.
Colorectal panel provides detailed cancer information - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.
Hereditary Colon Cancer Testing - Mayo Clinic Laboratories
Our algorithmic approach aids with the ordering process and guides physicians to ensure the right tests are being ordered at the right time for patients.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights
This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.
PACE / State of FLThis month’s “Virtual Lecture” recognizes the importance of tracking tumor cell development and the heterogeneity in cancer cell growth dynamics at the clonal resolution and reveals features of tumor cell metastasis.
Melanoma panel provides more tumor information - Insights
In this test specific episode of the "Answers From the Lab" podcast, Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' comprehensive melanoma panel better informs prognosis and treatment.
Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo...
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs,...
Building the business of lab medicine - Insights
In part three of the 50th Anniversary series, Mayo Clinic Laboratories looks further outside the walls of Mayo Clinic. With the belief that the latest in diagnostic testing should be available to any patient, no matter where they are...
The birth of Mayo Clinic Laboratories: From tiny operation to international mainstay - Insights
In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and...
Lisa Brown, quality specialist for Mayo Clinic Laboratories customer service, explains working "behind the scenes" when a client calls Mayo Clinic Laboratories with an inquiry, that call is typically picked up within 20 seconds by an agent...
How the COVID-19 pandemic has increased public knowledge of lab testing - Insights
While the accelerated innovation and increased access to testing that’s occurred because of the COVID-19 pandemic has been critically important to worldwide health care, so too has the crash course in laboratory testing and pathology the...
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...
The evolution of specimen accessioning and delivery - Insights
The last installment of our 50th Anniversary series explores how Mayo Clinic Laboratories pioneered best practices in the area of specimen accessioning and delivery.
Chromogenic Factor VIII and IX Assays: Impact on Diagnosis and Management of Hemophilia - Insights
In this month’s “Hot Topic,” Rajiv Pruthi, M.B.B.S., will discuss different types of hemophilia along with their pathologic basis. He will also cover various types of factor assays such as one stage and chromogenic factor assays for...
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
See how our Special Coagulation Laboratory offers algorithmic approaches to meet your bleeding disorder testing needs.
Connect with us at the 65th American Society of Hematology Annual Meeting and Exposition to learn how our evaluations can inform your clinical practice. Schedule a one-on-one session with our representatives.
Frequently asked questions - Insights
For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...
Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...
Frequently asked questions - Insights
For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...
Cutting-edge lab work cracks a medical mystery: Kenneth Hobby - Insights
Kenneth Hobby assumed his fever, fatigue, and aching pains in May 2018 were from another bout of malaria. He was on one of his frequent visits to Zambia in southern Africa, where the mosquito-borne parasite is common. But anti-malaria drugs...
NGS for Myeloid Neoplasm Evaluation - Insights
In this month's "Hot Topic," David Viswanatha, M.D., discusses updates to Mayo Clinic's next-generation sequencing (NGS) for myeloid neoplasm evaluation, involving new test targets, the rationale for new genetic regions, alignments with the...
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
Enhanced detection of genetic mutation to optimize leukemia treatment - Insights
Rong He, M.D., describes how Mayo Clinic Laboratories’ NPM1Q assay detects all known forms of a genetic mutation found in about 30% of people with acute myeloid leukemia, or AML. Identifying the NPM1 mutation is critical for clinical...
Lab Medicine Rounds Archives - Page 11 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Advancing our Understanding of Immunoglobulins to Better Understand Disease - Insights
PACE / State of FLIn this month’s “Virtual Lecture,” David Murray, M.D., Ph.D., discusses how immunoglobin light chains are used to detect overexpressed immunoglobins which can be applied to distinguish patients with plasma cell disorders...
Classification of Kidney Stone Composition Using an AI Model - Insights
PACE / State of FLThis month’s “Virtual Lecture,” discusses how artificial intelligence can be utilized to classify kidney stones while demonstrating improvement in quality and patient safety.